Fig. 3From: Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosaSimulated growth capabilities of 107 GEMs on various nutrient sources. a 107 strains are clustered by simulated growth capabilities on 143 differentiating nutrient sources. b Simulated growth on monosaccharides and their derivatives from mucus glycan. c Simulated growth on butyrate, fructoselysine and psicoselysineBack to article page